• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者外周血循环髓系来源抑制细胞(MDSC)的免疫表型分析。

Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.

机构信息

Experimental and Translational Research, Department of Otorhinolaryngology, University Hospital Essen, West German Cancer Center, Essen, Germany.

出版信息

Methods Mol Biol. 2021;2236:1-7. doi: 10.1007/978-1-0716-1060-2_1.

DOI:10.1007/978-1-0716-1060-2_1
PMID:33237535
Abstract

Myeloid-derived suppressor cells (MDSC) are a heterogeneous group of pathologically expanded myeloid cells with immunosuppressive activity. According to their phenotype, MDSC can be divided into three major subpopulations: early stage MDSC (e-MDSC), lacking myeloid lineage markers, monocytic MDSC (M-MDSC), and granulocytic MDSC (PMN-MDSC). Additionally, PMN-MDSC can be subdivided based on their activation and differentiation status, although it is not clear how this status contributes to immunosuppression and disease pathology. Here, we describe an immunophenotyping and gating strategy for the identification and isolation of MDSC subsets based on fluorescence-activated cell sorting. This method allows direct comparison of MDSC subsets in clinical settings.

摘要

髓系来源的抑制细胞(MDSC)是一群具有病态扩增和免疫抑制活性的异质性髓系细胞。根据其表型,MDSC 可分为三个主要亚群:早期 MDSC(e-MDSC),缺乏髓系谱系标记物;单核细胞来源的 MDSC(M-MDSC);粒细胞来源的 MDSC(PMN-MDSC)。此外,PMN-MDSC 可以根据其激活和分化状态进一步细分,尽管其状态如何有助于免疫抑制和疾病发病机制尚不清楚。在这里,我们描述了一种基于流式细胞术的免疫表型和门控策略,用于鉴定和分离 MDSC 亚群。该方法允许在临床环境中直接比较 MDSC 亚群。

相似文献

1
Immunophenotyping of Circulating Myeloid-Derived Suppressor Cells (MDSC) in the Peripheral Blood of Cancer Patients.癌症患者外周血循环髓系来源抑制细胞(MDSC)的免疫表型分析。
Methods Mol Biol. 2021;2236:1-7. doi: 10.1007/978-1-0716-1060-2_1.
2
Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.人类髓源性抑制细胞亚群的临床相关性和抑制能力。
Clin Cancer Res. 2018 Oct 1;24(19):4834-4844. doi: 10.1158/1078-0432.CCR-17-3726. Epub 2018 Jun 18.
3
Immunosuppressive effects and mechanisms of three myeloid-derived suppressor cells subsets including monocytic-myeloid-derived suppressor cells, granulocytic-myeloid-derived suppressor cells, and immature-myeloid-derived suppressor cells.三种髓系来源的抑制细胞亚群(包括单核细胞-髓系来源的抑制细胞、粒细胞-髓系来源的抑制细胞和未成熟-髓系来源的抑制细胞)的免疫抑制作用及其机制。
J Cancer Res Ther. 2021 Jul-Sep;17(4):1093-1100. doi: 10.4103/jcrt.JCRT_1222_20.
4
In Vitro Generation of Human Neutrophilic Myeloid-Derived Suppressor Cells.体外生成人中性粒细胞髓系来源的抑制细胞。
Methods Mol Biol. 2021;2236:77-83. doi: 10.1007/978-1-0716-1060-2_8.
5
Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models.在小鼠癌症模型中分离和表型分析脾脏髓系来源的抑制细胞。
Methods Mol Biol. 2021;2236:19-28. doi: 10.1007/978-1-0716-1060-2_3.
6
Isolation of Human Circulating Myeloid-Derived Suppressor Cells and Analysis of Their Immunosuppressive Activity.人循环髓系来源的抑制细胞的分离及其免疫抑制活性分析。
Methods Mol Biol. 2021;2236:43-56. doi: 10.1007/978-1-0716-1060-2_5.
7
Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.结直肠癌患者循环髓源性抑制细胞亚群——对其生物标志物潜力的探索性分析
Klin Onkol. 2018 Winter;31(Suppl 2):88-92.
8
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation.循环中人类 MDSC 亚群在癌症、感染和炎症患者中的差异扩张。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001223.
9
Plasticity of myeloid-derived suppressor cells in cancer.髓系来源的抑制性细胞在癌症中的可塑性。
Curr Opin Immunol. 2018 Apr;51:76-82. doi: 10.1016/j.coi.2018.03.009. Epub 2018 Mar 14.
10
Flow cytometry-based immunophenotyping of myeloid-derived suppressor cells in human breast cancer patient blood samples.基于流式细胞术的人乳腺癌患者血液样本中髓源抑制细胞的免疫表型分析。
J Immunol Methods. 2022 Nov;510:113348. doi: 10.1016/j.jim.2022.113348. Epub 2022 Sep 2.

引用本文的文献

1
Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs).衰老调节血液来源的髓源性抑制细胞(MDSC)的免疫抑制、极化和代谢功能。
Immun Ageing. 2025 Jul 8;22(1):29. doi: 10.1186/s12979-025-00524-w.
2
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease.髓源性抑制细胞在肝脏疾病中的作用。
Biomedicines. 2024 Jan 27;12(2):299. doi: 10.3390/biomedicines12020299.
3
HPV-associated head and neck cancer is characterized by distinct profiles of CD8 T cells and myeloid-derived suppressor cells.
HPV 相关的头颈部癌症的特征是 CD8 T 细胞和髓系来源的抑制细胞的独特特征。
Cancer Immunol Immunother. 2023 Dec;72(12):4367-4383. doi: 10.1007/s00262-023-03571-8. Epub 2023 Nov 29.
4
Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype.癌症患者血液中的免疫抑制性低密粒细胞表现出成熟的表型。
Life Sci Alliance. 2023 Nov 6;7(1). doi: 10.26508/lsa.202302332. Print 2024 Jan.
5
DAT and TH expression marks human Parkinson's disease in peripheral immune cells.多巴胺转运体(DAT)和酪氨酸羟化酶(TH)表达在外周免疫细胞中标记人类帕金森病。
NPJ Parkinsons Dis. 2022 Jun 7;8(1):72. doi: 10.1038/s41531-022-00333-8.
6
Mechanisms Underlying the Role of Myeloid-Derived Suppressor Cells in Clinical Diseases: Good or Bad.髓源性抑制细胞在临床疾病中作用的潜在机制:有益还是有害
Immune Netw. 2021 May 26;21(3):e21. doi: 10.4110/in.2021.21.e21. eCollection 2021 Jun.